Baycol and Cerebral infarction - a phase IV clinical study of FDA data

Summary:

Cerebral infarction is reported as a side effect among people who take Baycol (cerivastatin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Norvasc, and have Ill-defined disorder.

The phase IV clinical study analyzes which people have Cerebral infarction when taking Baycol. It is created by eHealthMe based on reports of 19,132 people who have side effects when taking Baycol from the FDA, and is updated regularly.

What is Baycol?

Baycol has active ingredients of cerivastatin sodium. eHealthMe is studying from 19,134 Baycol users. Check the latest studies of Baycol.

What is Cerebral infarction?

Cerebral infarction (less blood supply to brain resulting tissue damage) is found to be associated with 1,346 drugs and 1,498 conditions by eHealthMe. Check the latest studies of Cerebral infarction.

On Aug, 08, 2026

19,132 people reported to have side effects when taking Baycol.
Among them, 20 people (0.1%) have Cerebral infarction.

Among these 20 people:

How long have people been on Baycol when they have Cerebral infarction? *

What is the gender of people who have Cerebral infarction when taking Baycol? *

female: 40 %
male: 60 %

What is the age of people who have Cerebral infarction when taking Baycol? *

What are other drugs people take besides Baycol? *

What are other side effects people have besides Cerebral infarction? *

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 5 people, 25.00%
Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 4 people, 20.00%
Speech Impairment (Adult) (inability to speak (adult)): 4 people, 20.00%
Weakness: 3 people, 15.00%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 3 people, 15.00%
Bell's Palsy (facial paralysis): 3 people, 15.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 15.00%
Agitation (state of anxiety or nervous excitement): 2 people, 10.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 10.00%
Fainting (loss of consciousness and postural tone): 2 people, 10.00%

What are the existing conditions these people have? *

Type 2 Diabetes: 1 person, 5.00%
Pain: 1 person, 5.00%
Ill-Defined Disorder: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Baycol and have Cerebral infarction?

- Check whether Cerebral infarction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Baycol:

Baycol (19,134 reports)

Browse all side effects of Baycol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cerebral infarction:

Cerebral infarction (1,346 drugs)

Browse all the conditions that are associated with Cerebral infarction:

Cerebral infarction (1,498 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cerivastatin sodium (the active ingredients of Baycol) and Baycol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.